Inspired by the writings of Joseph Campbell, I’ve been practicing the art of tarot divination for over two decades in my personal life with uncannily accurate results. A little over a year ago, I ported this method of assessment over into the field of biotechnology stock analysis. I was stunned to find that it presented an array of information that was accurate, actionable and predictive of binary outcomes.
I do not claim to possess any power of divination. Nor do I profess a great knowledge of the tarot which I utilize to predict company performance and investor attitudes over a 4 – 6 month period of time. Rather, my guides reconnoiter on my behalf culling information of import from company executives, trial leaders and FDA personnel in but a few passing moments. They then convey a survey of their impressions back to me for interpretation.
It’s important for you to know that my guides never fail me and their information is flawless. However, the interpretive aspect of the process is skill based, subject to human error and ever evolving.
Always be well…